Memora Health Announces Partnership with Moffitt Cancer Centre

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Endo Announces Peyronie’s Disease Presentation at...

Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today...

Leadership at NHS Hospitals in Leeds...

A watchdog has gone on to say that the...

Developing Dr. CaBot, A Medical Education...

Harvard Medical School researchers are developing Dr. CaBot as...

UK & U.S. Regulators Partner for...

The medicines regulator of the UK has announced plans...

Memora Health announced a partnership with Moffitt Cancer Center. The first-of-its-kind partnership will bring together Moffitt’s expertise in oncology with Memora’s clinical intelligence care platform to improve the patient experience; and enable Moffitt’s clinicians and providers to utilise the platform directly in support of critical patient needs.

Memora Health offers Moffitt Cancer Centre a unique opportunity to utilise clinical expertise and reach for driving high-touch, patient-centric care. This innovative partnership will improve oncology care across a broader audience of providers and allow Moffitt to utilise the care programmes to improve care for the serving patients.

Memora’s platform simplifies complex care delivery for patients and providers by automating care journeys. The programme provides 24/7, two-way communications with patients care, and intelligently triages patient questions and clinical concerns to the appropriate care team members.

The programme provides 2-hour two-way communication with patients about their care and intelligently directs patient questions and clinical concerns to the appropriate members of the care team.

Latest stories

Related stories

Developing Dr. CaBot, A Medical Education Tool That Reasons

Harvard Medical School researchers are developing Dr. CaBot as...

UK & U.S. Regulators Partner for Medtech Regulatory Reforms

The medicines regulator of the UK has announced plans...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »